ROSSARI — Rossari Biotech Income Statement

0.000.00%

Last trade - 00:00

Basic MaterialsBalancedSmall CapNeutral

Annual income statement for Rossari Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7,093	14,830	16,559	18,306	20,803
Cost of Revenue
Gross Profit	2,472	3,779	4,846	5,370	6,470
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	6,091	13,427	14,958	16,479	18,931
Operating Profit	1,002	1,403	1,601	1,827	1,872
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,068	1,363	1,442	1,776	1,852
Provision for Income Taxes
Net Income After Taxes	800	977	1,073	1,307	1,364
Minority Interest
Net Income Before Extraordinary Items
Net Income	802	977	1,073	1,307	1,364
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	802	977	1,073	1,307	1,364
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	15.4	17	19.3	23.4	24.6
Dividends per Share